A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae
- PMID: 35637031
- DOI: 10.1016/j.jinf.2022.05.004
A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae
Comment on
-
Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study.J Infect. 2022 May;84(5):637-647. doi: 10.1016/j.jinf.2022.03.010. Epub 2022 Mar 14. J Infect. 2022. PMID: 35301013
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
